Cenova Capital is one of the earliest healthcare dedicated funds in China founded in 2010 by Dr Jun WU and is one of the earliest investors in private healthcare services and digital health, with helps to facilitate the transformation of healthcare in China from an exclusively state-owned system to a more efficient, market-oriented system.
Through the years, Cenova has built a reputation among its current and potential portfolio companies, industry leaders, multinational companies and its peers, as a leading fund for life science investments in China.
Currently, Cenova has five funds under management invested in over 50 companies with a proven track record across three funds. Its investors include large domestic and international institutional investors including Asian sovereign wealth funds, government institutions, insurance and financial institutions and multinational companies.
The Fund invest in mostly late stage venture and growth stage companies in the life sciences and healthcare product and services sectors.